FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

30023811000001100: Disopyramide 150mg capsules (Mawdsley-Brooks & Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Aug 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
93687901000001113 Disopyramide 150mg capsules (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
93688001000001110 Disopyramide 150mg capsules (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Disopyramide 150mg capsules (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Disopyramide 150mg capsules (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Disopyramide 150mg capsules (Mawdsley-Brooks & Company Ltd) Is a Disopyramide 150mg capsules false Inferred relationship Existential restriction modifier
Disopyramide 150mg capsules (Mawdsley-Brooks & Company Ltd) Is a Disopyramide 150mg capsules true Inferred relationship Existential restriction modifier
Disopyramide 150mg capsules (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Disopyramide 150mg capsules (Mawdsley-Brooks & Company Ltd) Is a Product containing precisely disopyramide phosphate 150 milligram/1 each conventional release oral capsule false Inferred relationship Existential restriction modifier
Disopyramide 150mg capsules (Mawdsley-Brooks & Company Ltd) Has active ingredient Disopyramide phosphate false Inferred relationship Existential restriction modifier
Disopyramide 150mg capsules (Mawdsley-Brooks & Company Ltd) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Disopyramide 150mg capsules (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Disopyramide 150mg capsules (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Disopyramide 150mg capsules (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Disopyramide true Inferred relationship Existential restriction modifier
Disopyramide 150mg capsules (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Disopyramide 150mg capsules (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Disopyramide 150mg capsules (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Disopyramide 150mg capsules (Mawdsley-Brooks & Company Ltd) 84 capsule Has AMP True Disopyramide 150mg capsules (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start